Carcinogenesis in reflux disease - In search for bile-specific effects

Microsurgery

Volumn 27, Issue 8, 2007, Pages 647-650

  Fein, Martin ^a   Peters, Jeffrey H ^b   Demeester, Tom R ^c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ESOPHAGITIS; ESOPHAGOJEJUNOSTOMY; ESOPHAGUS MUCOSA; GASTROESOPHAGEAL REFLUX; MALE; MEDICAL RESEARCH; MOUSE; MUTAGENESIS; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; TOTAL STOMACH RESECTION;

ADENOCARCINOMA; ANIMALS; BILE REFLUX; CARCINOGENICITY TESTS; CARCINOGENS; DISEASE MODELS, ANIMAL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MUTATION;

EID: 36448930202     PISSN: 07381085     EISSN: 10982752     Source Type: Journal    
DOI: 10.1002/micr.20424     Document Type: Article

References (37)

1. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-1289.
2. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-513.
3. Devesa SS, Blot WJ, Fraumeni JFJ. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-2053.
4. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-831.
5. Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1998;93:1028-1032.
6. Jankowski JA, Harrison RF, Perry I, Balkwill F, Tselepis C. Barrett's metaplasia. Lancet 2000;356:2079-2085.
7. Champion G, Richter JE, Vaezi MF, Singh S, Alexander R. Duodenogastroesophageal reflux: Relationship to pH and importance in Barrett's esophagus. Gastroenterology 1994;107:747-754.
8. Kauer WK, Peters JH, DeMeester TR, Ireland AP, Bremner CG, Hagen JA. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg 1995;222:525-531.
9. Caldwell MTP, Lawlor P, Byrne PJ, Walsh TN, Hennessy TPJ. Ambulatory oesophageal bile reflux monitoring in Barrett's oesophagus. Br J Surg 1995;82:657-660.
10. Fein M, Ireland AP, Ritter MP, Peters JH, Hagen JA, Bremner CG, DeMeester TR. Duodenogastric reflux potentiates the injurious effects of gastroesophageal reflux. J Gastrointest Surg 1997;1:27-33.
11. Pera M, Cardesa A, Bombi JA, Ernst H, Pera C, Mohr U. Influence of esophagojejunostomy on the induction of adenocarcinoma of the distal esophagus in Sprague-Dawley rats by subcutaneous injection of 2,6- dimethylnitrosomorpholine. Cancer Res 1989;49:6803-6808.
12. Attwood SE, Smyrk TC, DeMeester TR, Mirvish SS, Stein HJ, Hinder RA. Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery 1992;111:503-510.
13. Ireland AP, Peters JH, Smyrk TC, DeMeester TR, Clark GW, Mirvish SS, Adrian TE. Gastric juice protects against the development of esophageal adenocarcinoma in the rat. Ann Surg 1996;224:358-371.
14. Miwa K, Sahara H, Segawa M, Kinami S, Sato T, Miyazaki I, Hattori T. Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 1996;67:269-274.
15. Goldstein SR, Yang GY, Curtis SK, Reuhl KR, Liu BC, Mirvish SS, Newmark HL, Yang CS. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis 1997;18:2265-2270.
16. Fein M, Peters JH, Chandrasoma P, Ireland AP, Öberg S, Ritter MP, Bremner CG, Hagen JA, DeMeester TR. Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg 1998;2:260-268.
17. Miwa K, Hattori T, Miyazaki I. Duodenogastric reflux and foregut carcinogenesis. Cancer 1995;75:1426-1432.
18. Mirvish SS. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett 1995;93:17-48.
19. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B. Identification of a nuclear receptor for bile acids. Science 1999;284:1362-1365.
20. de Gottardi A, Touri F, Maurer CA, Perez A, Maurhofer O, Ventre G, Bentzen CL, Niesor EJ, Dufour JF. The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer. Dig Dis Sci 2004;49:982-989.
21. Wetscher GJ, Hinder RA, Bagchi D, Hinder PR, Bagchi M, Perdikis G, McGinn T. Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am J Surg 1995;170:552-556.
22. Chen X, Ding YW, Yang G, Bondoc F, Lee MJ, Yang CS. Oxidative damage in an esophageal adenocarcinoma model with rats. Carcinogenesis 2000;21:257-263.
23. Kohler SW, Provost GS, Fieck A, Kretz PL, Bullock WO, Sorge JA, Putman DL, Short JM. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Proc Natl Acad Sci USA 1991;88:7958-7962.
24. Stuart GR, Glickman BW. Through a glass, darkly: Reflections of mutation from lacI transgenic mice. Genetics 2000;155:1359-1367.
25. Theisen J, Peters JH, Fein M, Hughes M, Hagen JA, DeMeester SR, DeMeester TR, Laird PW. The mutagenic potential of duodenoesophageal reflux. Ann Surg 2005;241:63-68.
26. Fein M, Peters JH, Baril N, McGarvey M, Chandrasoma P, Shibata D, Laird PW, Skinner KA. Loss of function of Trp53, but not Apc, leads to the development of adenocarcinoma in mice with jejunoesophageal reflux. J Surg Res 1999;83:48-55.
27. Xu X, LoCicero J, Macri E, Loda M, Ellis FHJ. Barrett's esophagus and associated adenocarcinoma in a mouse surgical model. J Surg Res 2000;88:120-124.
28. http://stratagene.com/manuals/720201.pdf. 2007.
29. http://stratagene.com/manuals/200223.pdf. 2007.
30. Tao KS, Urlando C, Heddle JA. Mutagenicity of methyl methanesulfonate (MMS) in vivo at the Dlb-1 native locus and a lacI transgene. Environ Mol Mutagen 1993;22:293-296.
31. Morrison V, Ashby J. A preliminary evaluation of the performance of the Muta Mouse (lacZ) and Big Blue (lacI) transgenic mouse mutation assays. Mutagenesis 1994;9:367-375.
32. Fein M, Fuchs KH, Stopper H, Diem S, Herderich M. Duodenogastric reflux and foregut carcinogenesis: Analysis of duodenal juice in a rodent model of cancer. Carcinogenesis 2000;21:2079-2084.
33. Chen X, Li N, Wang S, Hong J, Fang M, Yousselfson J, Yang P, Newman RA, Lubet RA, Yang CS. Aberrant arachidonic acid metabolism in esophageal adenocarcinogenesis, and the effects of sulindac, nordihydroguaiaretic acid, and α-difluoromethylornithine on tumorigenesis in a rat surgical model. Carcinogenesis 2002;23:2095-2102.
34. Jang TJ, Min SK, Bae JD, Jung KH, Lee JI, Kim JR, Ahn WS. Expression of cyclooxygenase 2, microsomal prostaglandin E synthase 1, and EP receptors is increased in rat oesophageal squamous cell dysplasia and Barrett's metaplasia induced by duodenal contents reflux. Gut 2004;53:27-33.
35. Moore SR, Hill KA, Heinmoller PW, Halangoda A, Kunishige M, Buettner VL, Graham KS, Sommer SS. Spontaneous mutation frequency and pattern in Big Blue mice fed a vitamin E-supplemented diet. Environ Mol Mutagen 1999;34:195-200.
36. Takahashi S, Ikeda Y, Kimoto N, Okochi E, Cui L, Nagao M, Ushijima T, Shirai T. Mutation induction by mechanical irritation caused by uracil-induced urolithiasis in Big Blue rats. Mutat Res 2000;447:275-280.
37. Motorna OO, Martin H, Gentile GJ, Gentile JM. Analysis of lacI mutations in Big Blue transgenic mice subjected to parasite-induced inflammation. Mutat Res 2001;484:69-76.